Renaissance Technologies’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Buy |
1,670,012
+113,312
| +7% | +$128K | ﹤0.01% | 2146 |
|
|
2025
Q1 | $2.27M | Buy |
1,556,700
+1,002,159
| +181% | +$1.46M | ﹤0.01% | 1921 |
|
|
2024
Q4 | $1.18M | Sell |
554,541
-87,468
| -14% | -$186K | ﹤0.01% | 2398 |
|
|
2024
Q3 | $1.8M | Sell |
642,009
-1,105,946
| -63% | -$3.1M | ﹤0.01% | 2095 |
|
|
2024
Q2 | $4.07M | Buy |
1,747,955
+1,351,055
| +340% | +$3.15M | 0.01% | 1442 |
|
|
2024
Q1 | $1.77M | Sell |
396,900
-61,748
| -13% | -$276K | ﹤0.01% | 2111 |
|
|
2023
Q4 | $1.47M | Buy |
458,648
+428,366
| +1,415% | +$1.37M | ﹤0.01% | 2153 |
|
|
2023
Q3 | $96K | Sell |
30,282
-221,618
| -88% | -$703K | ﹤0.01% | 3255 |
|
|
2023
Q2 | $1.25M | Sell |
251,900
-176,800
| -41% | -$879K | ﹤0.01% | 2329 |
|
|
2023
Q1 | $2.12M | Sell |
428,700
-11,400
| -3% | -$56.3K | ﹤0.01% | 1990 |
|
|
2022
Q4 | $2.77M | Buy |
+440,100
| New | +$2.77M | ﹤0.01% | 1876 |
|
|
2022
Q2 | – | Sell |
-974,700
| Closed | -$8.88M | – | 4188 |
|
|
2022
Q1 | $8.88M | Buy |
+974,700
| New | +$8.88M | 0.01% | 1195 |
|
|
2021
Q3 | – | Sell |
-704,400
| Closed | -$18.4M | – | 3440 |
|
|
2021
Q2 | $18.4M | Buy |
+704,400
| New | +$18.4M | 0.02% | 801 |
|
|
2020
Q4 | – | Sell |
-83,900
| Closed | -$3.16M | – | 3356 |
|
|
2020
Q3 | $3.16M | Buy |
83,900
+58,700
| +233% | +$2.21M | ﹤0.01% | 1853 |
|
|
2020
Q2 | $1.08M | Buy |
+25,200
| New | +$1.08M | ﹤0.01% | 2499 |
|